Cite
18F-FDG PET/CT and histology for diagnosing recurrent/remnant tumors in head and neck cancer patients treated with radiotherapy.
MLA
Eun Ji Han, et al. “18F-FDG PET/CT and Histology for Diagnosing Recurrent/Remnant Tumors in Head and Neck Cancer Patients Treated with Radiotherapy.” Hellenic Journal of Nuclear Medicine, vol. 20, no. 2, May 2017, pp. 134–40. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=124883343&authtype=sso&custid=ns315887.
APA
Eun Ji Han, Joo Hyun O., Ie Ryung Yoo, Yeon Sil Kim, Min Sik Kim, Jin Hyoung Kang, & Woo Hee Choi. (2017). 18F-FDG PET/CT and histology for diagnosing recurrent/remnant tumors in head and neck cancer patients treated with radiotherapy. Hellenic Journal of Nuclear Medicine, 20(2), 134–140.
Chicago
Eun Ji Han, Joo Hyun O., Ie Ryung Yoo, Yeon Sil Kim, Min Sik Kim, Jin Hyoung Kang, and Woo Hee Choi. 2017. “18F-FDG PET/CT and Histology for Diagnosing Recurrent/Remnant Tumors in Head and Neck Cancer Patients Treated with Radiotherapy.” Hellenic Journal of Nuclear Medicine 20 (2): 134–40. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=124883343&authtype=sso&custid=ns315887.